Cargando…
In vitro and In vivo Model Systems for Hemophilia A Gene Therapy
Hemophilia A is a hereditary disorder caused by various mutations in factor VIII gene resulting in either a severe deficit or total lack of the corresponding activity. Recent success in gene therapy of a related disease, hemophilia B, gives new hope that similar success can be achieved for hemophili...
Autores principales: | Mao, Jianhua, Xi, Xiaodong, Kapranov, Philipp, Dong, Biao, Firrman, Jenni, Xu, Ruian, Xiao, Weidong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229687/ https://www.ncbi.nlm.nih.gov/pubmed/25401041 http://dx.doi.org/10.4172/2157-7412.S1-014 |
Ejemplares similares
-
Evaluation of the biological differences of canine and human factor VIII in gene delivery: implications in human hemophilia treatment
por: Wang, Qizhao, et al.
Publicado: (2016) -
Syngeneic AAV Pseudo-particles Potentiate Gene Transduction of AAV Vectors
por: Wang, Qizhao, et al.
Publicado: (2016) -
A concept of eliminating nonhomologous recombination for scalable and safe AAV vector generation for human gene therapy
por: Dong, Biao, et al.
Publicado: (2013) -
Ultrasound-mediated gene delivery of factor VIII plasmids for hemophilia A gene therapy in mice
por: Song, Shuxian, et al.
Publicado: (2022) -
Adenoviral Vectors for Hemophilia Gene Therapy
por: Brunetti-Pierri, N, et al.
Publicado: (2013)